(Q41906964)

13 October 2017

Development of interferon γ-based immunocytokines targeting renal cancer (English)

1 reference

13 October 2017

Peirong Chen

1

1 reference

PMC publication ID

3782162

13 October 2017

Siddharth Balachandran

series ordinal

2

1 reference

13 October 2017

16 May 2013

1 reference

13 October 2017

1 reference

13 October 2017

2

1 reference

13 October 2017

7

1 reference

13 October 2017

e24964

1 reference

Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinoma

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

Interferon-γ-induced necrosis: an antitumor biotherapeutic perspective

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

Immunocytokines: a novel class of potent armed antibodies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

The emerging role of nuclear factor kappa B in renal cell carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

The epidemiology of renal cell carcinoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

Targeting CD70 for human therapeutic use.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

Mechanisms of proteasome inhibitor action and resistance in cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

IFNalpha/beta promotes cell survival by activating NF-kappa B

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782162

5 June 2018

Identifiers

DOI

10.4161/ONCI.24964

1 reference

13 October 2017

1 reference

PMC publication ID

3782162

13 October 2017

PubMed publication ID

24073376

1 reference

PMC publication ID

3782162